|
|
Volumn 50, Issue 4, 2012, Pages 281-289
|
|
Cost comparison of outpatient treatment with granulocyte colony-stimulating factors (G-CSF) in Germany.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BIOSIMILAR AGENT;
GRANULOCYTE COLONY STIMULATING FACTOR;
RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;
RECOMBINANT PROTEIN;
ADULT;
AGED;
AMBULATORY CARE;
ARTICLE;
COMPARATIVE STUDY;
COST BENEFIT ANALYSIS;
COST CONTROL;
DATA BASE;
DRUG COST;
ECONOMICS;
FEMALE;
GERMANY;
HEALTH INSURANCE;
HUMAN;
MALE;
MIDDLE AGED;
NATIONAL HEALTH SERVICE;
NEUTROPENIA;
PRESCRIPTION;
REGRESSION ANALYSIS;
STATISTICAL MODEL;
TIME;
TREATMENT OUTCOME;
ADULT;
AGED;
AMBULATORY CARE;
BIOSIMILAR PHARMACEUTICALS;
COST SAVINGS;
COST-BENEFIT ANALYSIS;
DATABASES AS TOPIC;
DRUG COSTS;
DRUG PRESCRIPTIONS;
FEMALE;
GERMANY;
GRANULOCYTE COLONY-STIMULATING FACTOR;
HUMANS;
INSURANCE, PHARMACEUTICAL SERVICES;
MALE;
MIDDLE AGED;
MODELS, ECONOMIC;
NEUTROPENIA;
OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE);
RECOMBINANT PROTEINS;
REGRESSION ANALYSIS;
STATE MEDICINE;
TIME FACTORS;
TREATMENT OUTCOME;
|
|
EID: 84861422605
PISSN: 09461965
EISSN: None
Source Type: Journal
DOI: 10.5414/CP201633 Document Type: Article |
|
Times cited : (23)
|
|
References (0)
|
